Insights & Discussion
Pomegranate demonstrates anti-proliferative, anti-oxidant, anti-inflammatory properties that can effectively control the progression of various respiratory diseases.
The research methodology involved both in vivo and in vitro studies to examine the potential effects of pomegranate fruit, juice, extract, peel powder, and oil on a variety of respiratory disorders such as asthma, lung cancer, and chronic obstructive pulmonary disease. The focus was to understand the properties of pomegranates that led to its anti-proliferative, anti-oxidant, anti-microbial, anti-inflammatory, anti-cancer, and anti-tumorigenic effects, and how these qualities could potentially attenuate these diseases through modulation of various signaling pathways.
The discussion of results revealed that pomegranate was effective in controlling the progression of diverse respiratory diseases, suggesting it could be a key therapeutic target. These results not only demonstrated the potential medical benefits of pomegranate against lung-based diseases but also highlighted its possible role in influencing the lung fibrinolytic system. The findings from both preclinical and clinical studies underscored the influence of pomegranate in tackling lung diseases.
Discover Related Insights
Pomegranate extract supplements can help improve clinical symptoms and lower blood cell counts associated with inflammation in patients with allergic asthma.
2023 Frontiers in Pharmacology Does pomegranate extract supplementation improve the clinical symptoms of patients with allergic asthma? A double-blind, randomized, placebo-controlled trial Hosseini SA, Shateri Z, Abolnezhadian F, Maraghi E, Haddadzadeh Shoushtari M, Zilaee M
Randomised Controlled Trial Pomegranate
In this study, 64 participants with mild to moderate allergic asthma were randomly divided into two groups: a control group which was given placebo capsules and an intervention group which was given pomegranate extract capsules. The intervention group was administered a dosage of 250 milligrams of pomegranate extract twice daily over a period of eight weeks. The clinical symptoms and blood cell counts of all the participants were measured before starting the intervention and post the completion of it.
The results of the study indicated that the group which was given pomegranate extract exhibited considerable improvement in clinical symptoms like shortness of breath and restrictions on activity, as compared to the control group. Additionally, the participants in the intervention group displayed a substantive drop in eosinophil, basophil, and neutrophil counts. Notably, there was a statistically significant difference in the neutrophil and eosinophil levels between the two groups, which suggests that pomegranate extract supplementation might have potential therapeutic benefits for asthma patients.
HuoXiang ZhengQi (HQXXD) may be a safe and effective treatment for Chronic Cough Variant Asthma (CVA), improving clinical efficacy and airway responsiveness while reducing recurrence rates.
2022 Evidence-Based Complementary and Alternative Medicine The Effectiveness and Safety of Huangqi Xixin Decoction for Cough Variant Asthma: A Systematic Review and Meta-Analysis Wang C, Xia Q, Hu B, Jiang W, Zhang H
Systematic Review Cough Huang Qi Huangqi Xixin decoction
HuoXiang ZhengQi (HQXXD) for Chronic Cough Variant Asthma (CVA) was systematically evaluated. The HQXXD group showed significantly higher total effective rates of clinical efficacy and airway responsiveness compared to the control group, while the recurrence rate was lower. Adverse reactions were not reported in HQXXD treatment, indicating its safety for CVA patients.
Asthma severity can be notably reduced by Xi Xin essential oil, which decreases inflammation, immunoglobulins, and fibrotic mediators, while also alleviating airway obstruction.
2022 Pharmaceutics Exploring the Potential Effects and Mechanisms of Asarum sieboldii Radix Essential Oil for Treatment of Asthma Han JM, Kim MH, Choi LY, Kim G, Yang WM
Network Pharmacology Xi Xin
AEO was administered via a nebulizer for three weeks ahead of exposing mice to ovalbumin (OVA), a protein commonly used to provoke an allergic reaction, and particulate matter (PM), common air pollutants. Co-treatment of AEO, OVA, and PM was carried out for four weeks. Additionally, A549 lung epithelial cells were exposed to PM to study the influence of AEO on lung-fibrosis-related factors.
In our study, we found that AEO notably inhibited goblet cell accumulation, which led to a decrease in epithelial thickness. Collagen deposition in lung tissues, a common marker of airway remodeling, was significantly inhibited by AEO in asthmatic mice exposed to OVA and PM. AEO also lessened the influx of inflammatory cells into the bronchoalveolar lavage fluid, an indicator of respiratory inflammation. Similarly, the increases in serum IgE and IgG, immunoglobulins associated with allergic reactions, and cytokines in lung tissues were reduced by AEO. Moreover, AEO successfully managed the expression of key fibrotic mediators, particularly POSTN and TGF-β. All these indicators point to AEO's potential as a promising therapeutic treatment to alleviate asthma symptoms.
Honey, traditionally a food item, exhibits therapeutic properties—anti-microbial, anti-inflammatory, anti-cancer, and wound healing—showing promise in managing and preventing allergic diseases, as supported by scientific evidence and clinical studies.
2021 Frontiers in Pharmacology The Potential use of Honey as a Remedy for Allergic Diseases: A Mini Review Aw Yong PY, Islam F, Harith HH, Israf DA, Tan JW, Tham CL
Review Article Allergy Eczema Honey
This mini review explores honey's transition from a conventional food to a potential treatment for allergic diseases. Emphasis is placed on its diverse therapeutic properties, particularly its ability to alleviate pathological conditions and regulate inflammatory cell recruitment in cellular and animal models.
Scientific evidence and clinical studies suggest that honey holds potential in relieving allergic symptoms, offering a promising treatment or preventive approach for allergic diseases such as anaphylaxis, asthma, and atopic dermatitis. The review provides valuable insights for considering honey in clinical settings for allergic disease management.
Chinese herbal medicine usage in children with asthma can reduce their risk of hospitalization.
2020 Journal of Traditional and Complementary Medicine Long-term use of Chinese herbal medicine therapy reduced the risk of asthma hospitalization in school-age children: A nationwide population-based cohort study in Taiwan Lo PC, Lin SK, Lai JN
Cohort Study Chinese Herbal Medicine
The study used data from one million individuals randomly selected from the National Health Insurance Research Database's Registry of Beneficiaries. Children under 18 years old diagnosed with asthma were followed from the year 2000 to 2012. These patients were classified into two groups: the Chinese Herbal Medicine (CHM) group and the non-CHM group. The Kaplan-Meier survival curve and Cox proportional hazard regression model were utilized to estimate the adjusted hazard ratio of the two groups and to determine the correlation between the number of cumulative days the CHM was used and consequent hospitalizations due to asthma.
After adjusting for variables such as gender, age, comorbidities, and the total numbers of asthma medications taken, it was found that users of CHM had a reduced risk of hospitalization due to asthma compared to non-CHM users. Children older than six years who used CHM therapy for more than 180 days demonstrated a significant reduction in the risk of subsequent hospitalization for asthma.
Sign In
Users not signed in are limited to viewing the 5 most recent items of content.